scholarly journals Lifestyle change predictors in the general population

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
G Stirparo ◽  
M Bini ◽  
A Odone ◽  
C Signorelli
Keyword(s):  
Cardiovascular Disease ◽  
General Population ◽  
Cardiovascular Prevention ◽  
Lifestyle Change ◽  
Male Gender ◽  
Lifestyle Changes ◽  
Main Role ◽  
Prevention Campaign ◽  
History Of ◽  
European Society Of Cardiology

Abstract Background Even thought lifestyle changes have a main role in cardiovascular disease prevention, people show a weak adherence to medical advices. Aim of our study was to identify anamnestic predictors of poor compliance for lifestyle changes in a general population. Methods We submitted a 26 questions questionnaire to 301 general population subjects, investigating multiple anamnestic characteristics. Afterwards, we proceeded to explain people the main line of the European society of Cardiology guidelines on Cardiovascular prevention. Finally, we asked the subjects if this prevention campaign was able to modify their lifestyle. Results Sixty-four percent of interviewed were prone to change their lifestyle. Females answered positively more than males (73% vs 59%, p = 0.011). In terms of cardiovascular risk factors only the presence of dyslipidemia was significantly associated with a will of change (84% vs 58%, p = 0.000). Age (49 (18) vs 46 (20) ), familiar history of cardiovascular disease (69% vs 63%,p=0.320) and the presence of a previous cardiovascular event (68% vs 66%,p=0.841), do not predict the adherence to lifestyle change. Key messages Cardiovascular disease dose not influence people’s decision in life style change. Male gender represents an anamnestic characteristics that predict a poor adherence to lifestyle changes while people affected by dyslipidemia more frequently are prone to modify their routine.

Abstract WP226: The Association of Green Tea and Coffee Consumption With Mortality From Cardiovascular Disease and All Causes Among Persons With and Without History of Stroke or Myocardial Infarction: The JACC Study

Stroke ◽  
2020 ◽  
Vol 51 (Suppl_1) ◽  
Author(s):  
Masayuki Teramoto ◽  
Isao Muraki ◽  
Kokoro Shirai ◽  
Akiko Tamakoshi ◽  
Hiroyasu Iso
Keyword(s):  
Myocardial Infarction ◽  
Cardiovascular Disease ◽  
General Population ◽  
Green Tea ◽  
Coffee Consumption ◽  
Tea Consumption ◽  
Food Frequency ◽  
All Cause Mortality ◽  
History Of

Background: Both green tea and coffee consumption have been associated with lower risks of mortality from cardiovascular disease (CVD) and all causes in general population, but little is known about those impact on persons with history of CVD. We examined the association of those consumption with these mortalities among persons with and without history of stroke or myocardial infarction in general population. Methods: The study subjects were 60,664 participants (896 stroke and 1751 myocardial infarction survivors and 58,017 persons with no history of stroke or myocardial infarction), aged 40-79 years at the baseline (1988-1990), who completed a lifestyle and medical history questionnaire including self-administered food frequency under the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study). Results: During the median follow-up of 18.5 years, a total of 12,745 (7,458 men and 5,287 women) deaths including 3,737 CVD deaths were documented. Green tea and coffee consumption were inversely associated with CVD and all-cause mortality among myocardial infarction survivors as well as persons without history of stroke or myocardial infarction. After adjustment for known cardiovascular risk factors, the lower risks of mortality from CVD and all-causes associated with frequent green tea consumption (5-6 and ≥7 cups/day) or coffee consumption (≥2 cups/day) remained statistical. Conclusions: Both green tea and coffee consumption were inversely associated with risks of CVD and all-cause mortality among myocardial infarction survivors and persons without history of stroke or myocardial infarction.

Cardiovascular disease prevention guidelines

ESC CardioMed ◽  
2018 ◽  
pp. 2834-2836
Author(s):  
Janet Wei
Keyword(s):  
Cardiovascular Disease ◽  
Risk Assessment ◽  
Cardiovascular Risk ◽  
American Heart Association ◽  
Cardiovascular Prevention ◽  
Heart Association ◽  
Prevention Guidelines ◽  
European Society Of Cardiology ◽  
Cholesterol Management ◽  
Prevention Of Cardiovascular Disease

Cardiovascular prevention guidelines recommend systemic cardiovascular risk assessment in women, recognizing that women have a high lifetime risk of cardiovascular disease. While there are differences in the approach to risk assessment, both the American Heart Association and the European Society of Cardiology recommend estimation of a 10-year risk of cardiovascular disease. This chapter discusses the guidelines for aspirin use, cholesterol management, and lifestyle factors for prevention of cardiovascular disease.

scholarly journals Secondary prevention and cardiovascular care across Europe: A survey of European Society of Cardiology members’ views

2019 ◽  
Vol 19 (3) ◽  
pp. 201-211 ◽  
Author(s):  
Donna Fitzsimons ◽  
Janina Stępińska ◽  
Mary Kerins ◽  
Massimo F Piepoli ◽  
Loreena Hill ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Secondary Prevention ◽  
European Society ◽  
Guideline Implementation ◽  
Cardiovascular Prevention ◽  
Evidence Base ◽  
Provision Of Services ◽  
Esc Guidelines ◽  
European Society Of Cardiology ◽  
Prevention Of Cardiovascular Disease

Introduction: Secondary prevention of cardiovascular disease is a significant clinical challenge and despite European Society of Cardiology (ESC) Guidelines, evidence confirms sub-optimal patient care. Aim: The aim of this study was to evaluate ESC members’ opinions on the current provision of cardiovascular prevention and rehabilitation services across Europe and explore barriers to guideline implementation. Method: Electronic surveys using a secure web link were sent to members of the ESC in eight purposively selected ESC affiliated countries. Results: A total of 479 professionals completed the survey, of whom 67% were cardiologists, 8.6% general physicians, 8.2% nurses and 16.2% other healthcare professionals. Respondents were predominantly (91%) practising clinicians, generally highly motivated regarding cardiovascular disease prevention, but most reported that secondary prevention in their country was sub-optimal. The main barriers to prevention were lack of available cardiac rehabilitation programmes and long-term follow-up, patients’ disease perception and professional attitudes towards prevention. While knowledge of the prevention guidelines was generally good, practices such as motivational counselling and better educational tools were called for to promote exercise, smoking cessation and for nutritional aspects. Conclusions: The provision of services focusing on the secondary prevention of cardiovascular disease varies greatly across Europe. Furthermore, despite ESC Guidelines and a strong evidence base supporting the efficacy of secondary prevention, the infrastructure and co-ordination of such care is lacking. In addition patient motivation is considered poor and some professionals remain unconvinced about the merits of prevention. The disappointing results outlined in this survey emphasise that improved tools are urgently required to educate both patients and professionals and confirm the priority of cardiovascular prevention internationally.

scholarly journals Preeclampsia, gestational diabetes and later risk of cardiovascular disease: Women’s experiences and motivation for lifestyle changes explored in focus group interviews

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Heidi L. Sandsæter ◽  
Julie Horn ◽  
Janet W. Rich-Edwards ◽  
Hege S. Haugdahl
Keyword(s):  
Cardiovascular Disease ◽  
Focus Group ◽  
Healthcare Professionals ◽  
Lifestyle Change ◽  
Lifestyle Changes ◽  
Focus Group Interviews ◽  
Cvd Risk ◽  
Changes In Pregnancy ◽  
Group Interviews ◽  
In Pregnancy

Abstract Background Preeclampsia (PE) and gestational diabetes mellitus (GDM) are both associated with increased risk of future cardiovascular disease (CVD). Knowledge of the relationship between these pregnancy complications and increased CVD risk enables early prevention through lifestyle changes. This study aimed to explore women’s experiences with PE and/or GDM, and their motivation and need for information and support to achieve lifestyle changes. Methods Systematic text condensation was used for thematic analysis of meaning and content of data from five focus group interviews with 17 women with PE and/or GDM, with a live birth between January 2015 and October 2017. Results This study provides new knowledge of how women with GDM and/or PE experience pregnancy complications in a Nordic healthcare model. It reveals the support they want and the important motivating factors for lifestyle change. We identified six themes: Trivialization of the diagnosis during pregnancy; Left to themselves to look after their own health; The need to process the shock before making lifestyle changes (severe PE); A desire for information about future disease risk and partner involvement; Practical solutions in a busy life with a little one, and; Healthcare professionals can reinforce the turning point. The women with GDM wanted healthcare professionals to motivate them to continue the lifestyle changes introduced during pregnancy. Those with severe PE felt a need for individualized care to ensure that they had processed their traumatic labor experiences before making lifestyle changes. Participants wanted their partner to be routinely involved to ensure a joint understanding of the need for lifestyle changes. Motivation for lifestyle changes in pregnancy was linked to early information and seeing concrete results. Conclusions Women with PE and GDM have different experiences of diagnosis and treatment, which will affect the follow-up interventions to reduce future CVD risk through lifestyle change. For GDM patients, lifestyle changes in pregnancy should be reinforced and continued postpartum. Women with PE should be informed by their general practitioner after birth, and given a plan for lifestyle change. Those with severe PE will need help in processing the trauma, and stress management should be routinely offered.

Prevention in cardiovascular disease and rehabilitation

ESC CardioMed ◽  
2018 ◽  
pp. 892-898
Author(s):  
Ugo Corrà
Keyword(s):  
Cardiovascular Disease ◽  
Cardiovascular Risk ◽  
Cardiovascular Prevention ◽  
Cost Effective ◽  
Lifestyle Changes ◽  
Therapeutic Interventions ◽  
Prolong Life Expectancy ◽  
Life Therapy ◽  
Risk Cost ◽  
The Impact

A major goal in cardiovascular medicine is to prolong life expectancy, and maintain quality of life. Therapy for cardiovascular disease (CVD) and for prevention should be administered according to guidelines, together with lifestyle interventions. CVD prevention is defined as a coordinated set of actions that are aimed at eliminating or minimizing the impact of CVDs and their related disabilities. Prevention of CVD, either by implementation of lifestyle changes or use of medication, is cost-effective in many scenarios: cost-effectiveness depends on baseline cardiovascular risk, cost of protective drugs or other therapeutic interventions, reimbursement procedures, and implementation of preventive strategies. Cardiovascular risk profile guides the preventive priorities, and management: the higher the risk, the more intense the action should be. Patients with documented CVD are at very high risk. Nonetheless, the increasing awareness of the importance of cardiovascular prevention is not yet matched by the resources and actions within healthcare systems, and referral and long-term compliance remain critical challenges, also for patients with documented CVD.

Stress bei Patienten: Stress als Prognosefaktor für Re-Infarkte bei koronarer Herzkrankheit

2018 ◽  
Vol 7 (05) ◽  
pp. 379-383
Author(s):  
Jian Li ◽  
Peter Angerer
Keyword(s):  
Cardiovascular Disease ◽  
Clinical Practice ◽  
Disease Prevention ◽  
Cardiac Rehabilitation ◽  
European Society ◽  
European Association ◽  
Cardiovascular Prevention ◽  
Cardiovascular Disease Prevention ◽  
European Guidelines ◽  
European Society Of Cardiology

ZusammenfassungBisher wurde Stress als Prognosefaktor bei koronarer Herzkrankheit nur wenig beachtet. Wir möchten in diesem Artikel einen aktualisierten und umfassenden Überblick darüber geben, welche Rolle Stress bei der Prognose der koronaren Herzkrankheit spielen könnte. Stress wurde in unterschiedlichen Domänen gemessen. Die Synthese der Forschungsevidenz lässt vermuten, dass Stress das Risiko für wiederholte klinische Ereignisse bei Patienten mit koronarer Herzkrankheit um 55% (95%-Konfidenzintervall 32 – 83%) erhöhen kann. Die „European Guidelines on Cardiovascular Disease Prevention in Clinical Practice“, 2016 von der European Society of Cardiology veröffentlicht, weisen besonders auf die Rolle von Stress und psychosozialen Risikofaktoren hin. Insbesondere die „Cardiac Rehabilitation Section“ der European Association of Cardiovascular Prevention and Rehabilitation schlägt eine 2-stufige Evaluation eines potenziellen Risikos durch Stress für die klinisch-kardiologische Praxis vor.

scholarly journals Pharmacological Primary Cardiovascular Prevention and Subclinical Atherosclerosis in Men: Evidence from the Aragon Workers’ Health Study

2021 ◽  
Vol 10 (5) ◽  
pp. 945
Author(s):  
Isabel Aguilar-Palacio ◽  
Sara Malo ◽  
Estibaliz Jarauta ◽  
Belén Moreno-Franco ◽  
Lina Maldonado ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Subclinical Atherosclerosis ◽  
Previous History ◽  
Cardiovascular Prevention ◽  
Preventive Treatment ◽  
Statin Treatment ◽  
Personal History ◽  
Health Study ◽  
Adult Males ◽  
History Of

The objective of this study is to describe the profile of primary preventive treatment for cardiovascular disease in adult males and to analyze the association between treatment profile and subclinical atherosclerosis. We selected male workers who had undergone ultrasound imaging and had no previous history of cardiovascular disease (n = 2138). Data on the consumption of primary cardiovascular drugs from the previous year were obtained. We performed bivariate analyses to compare patient characteristics according to cardiovascular treatment and the presence of subclinical atherosclerosis, and logistic regression models to explore the association between these two variables. Among participants with no personal history of cardiovascular disease, subclinical atherosclerosis was present in 77.7% and 31.2% had received some form of preventive treatment. Of those who received no preventive treatment, 73.6% had subclinical atherosclerosis. Cardiovascular preventive treatment was associated only with CACS > 0 (odds ratio (OR), 1.37; 95% confidence interval (95% CI), 1.06–1.78). Statin treatment was associated with a greater risk of any type of subclinical atherosclerosis (OR, 1.73) and with CACS > 0 (OR, 1.72). Subclinical atherosclerosis existed in almost 75% of men who had no personal history of cardiovascular disease and had not received preventive treatment for cardiovascular disease.

Sign in / Sign up

Export Citation Format

Share Document